Patents by Inventor Paul Harrington

Paul Harrington has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240148217
    Abstract: A floor cleaning system having a flat headed mop is provided. The system includes a bucket having a wringing assembly. A blade including a first angled portion is provided for that is adjacent a plurality of first openings for compressing the flat headed mop as it is inserted in the wringing assembly to remove dirt and debris accumulated during use. A second angled portion is provided for adjacent a plurality of second openings for compressing the flat headed mop as it is withdrawn from the wringing assembly.
    Type: Application
    Filed: December 21, 2023
    Publication date: May 9, 2024
    Inventors: Robert F. Smith, Joseph K. Patterson, William Harrington, Paul H. Adams
  • Publication number: 20240084401
    Abstract: Provided herein, in certain embodiments, are various methods, reagents, and devices for detection of multiple target nucleic acids in a sample, or multiple segments of a target nucleic acid in a sample, using a programmable nuclease. In certain embodiments, the present disclosure provides compositions of pools of guide nucleic acids, programmable nucleases, and detector nucleic acids and methods of using said compositions for detection of different segments of one target nucleic acid or different target nucleic acids in a sample.
    Type: Application
    Filed: October 6, 2022
    Publication date: March 14, 2024
    Inventors: Matthew VEROSLOFF, Clare FASCHING, Carley Gelenter HENDRIKS, Xin MIAO, James Paul BROUGHTON, Lucas Benjamin HARRINGTON, Janice Sha CHEN
  • Publication number: 20240076875
    Abstract: A shingle coating asphalt composition is provided that is produced from a paving grade asphalt. The asphalt composition comprises a paving-grade asphalt that has been modified with one or more polymer additives; and a secondary additive comprising one or more of a viscosity reducing agent, a wax, a salt of a fatty acid ester, and an amide of a fatty acid. The shingle coating asphalt coating composition is used to make a shingle. The shingle includes a substrate, the asphalt, and roofing granules.
    Type: Application
    Filed: November 8, 2023
    Publication date: March 7, 2024
    Inventors: Carmen Anthony LaTorre, Jacob Paul Honsvick, Christopher Patrick Kasprzak, Daniel James Buckwalter, Edward R. Harrington, Jonathan Ross Davis, Laurand Henry Lewandowski, David Michael Ploense, William Edwin Smith, Scott W. Schweiger, Ganesh Latta
  • Patent number: 11539211
    Abstract: An intelligent impedance injection module is for use with transmission lines in a power grid. The intelligent impedance injection module has a plurality of transformer-less impedance injector units and a controller. The controller changes injector gain of the impedance injector units to compensate for current swings in a transmission line.
    Type: Grant
    Filed: April 2, 2020
    Date of Patent: December 27, 2022
    Assignee: Smart Wires Inc.
    Inventor: Paul Harrington
  • Publication number: 20200395756
    Abstract: An intelligent impedance injection module is for use with transmission lines in a power grid. The intelligent impedance injection module has a plurality of transformer-less impedance injector units and a controller. The controller changes injector gain of the impedance injector units to compensate for current swings in a transmission line.
    Type: Application
    Filed: April 2, 2020
    Publication date: December 17, 2020
    Inventor: Paul Harrington
  • Patent number: 10206524
    Abstract: A checkout terminal for customers in a retail store. The terminal provides a path for products from a loading conveyor section, via a scanning section and a common transfer conveyor section, to reach a respective one of a plurality of plurality of packing stations to be bagged or packed by or for the customer. Conveniently, three of these packing stations are arranged substantially parallel to each other. Each packing station may be associated with a corresponding payment interface. Customer throughput is increased by providing multiple packing areas associated with one loading and scanning area, and customer convenience is improved by the faster and more efficient configuration of the checkout terminal.
    Type: Grant
    Filed: November 19, 2014
    Date of Patent: February 19, 2019
    Assignee: ASDA Stores Limited
    Inventors: Samantha McPherson, Zoe Brough, Nazim Cheema, Paul Harrington, Sarah Lawson, Paul Dennis
  • Patent number: 9817671
    Abstract: An extensible software application utilizes rules to initiate a behavior that performs operations that customize the extensible software application in a preferred manner. The behavior is applied when pre-defined events occur during execution of the extensible software application. The rules are provided by a third party developer in metadata that is separate from the extension's program code. The rules are based on expressions that define the events that need to take place during the execution of the extensible software application before the behavior is applied.
    Type: Grant
    Filed: June 30, 2014
    Date of Patent: November 14, 2017
    Assignee: MICROSOFT TECHNOLOGY LICENSING, LLC.
    Inventor: Paul Harrington
  • Publication number: 20160270562
    Abstract: A checkout terminal for customers in a retail store. The terminal provides a path for products from a loading conveyor section, via a scanning section and a common transfer conveyor section, to reach a respective one of a plurality of plurality of packing stations to be bagged or packed by or for the customer. Conveniently, three of these packing stations are arranged substantially parallel to each other. Each packing station may be associated with a corresponding payment interface. Customer throughput is increased by providing multiple packing areas associated with one loading and scanning area, and customer convenience is improved by the faster and more efficient configuration of the checkout terminal.
    Type: Application
    Filed: November 19, 2014
    Publication date: September 22, 2016
    Inventors: Samantha McPherson, Zoe Brough, Nazim Cheema, Paul Harrington, Sarah Lawson, Paul Dennis
  • Publication number: 20150378742
    Abstract: An extensible software application utilizes rules to initiate a behavior that performs operations that customize the extensible software application in a preferred manner. The behavior is applied when pre-defined events occur during execution of the extensible software application. The rules are provided by a third party developer in metadata that is separate from the extension's program code. The rules are based on expressions that define the events that need to take place during the execution of the extensible software application before the behavior is applied.
    Type: Application
    Filed: June 30, 2014
    Publication date: December 31, 2015
    Inventor: PAUL HARRINGTON
  • Patent number: 9096559
    Abstract: The present invention relates to a novel class of 4-carboxybenzylamino derivatives. The 4-carboxybenzylamino compounds can be used to treat cancer. The 4-carboxybenzylamino compounds can also inhibit histone deacetylase and are suitable for use in selectively inducing terminal differentiation, and arresting cell growth and/or apoptosis of neoplastic cells, thereby inhibiting proliferation of such cells. Thus, the compounds of the present invention are useful in treating a patient having a tumor characterized by proliferation of neoplastic cells. The compounds of the invention may also be useful in the prevention and treatment of TRX-mediated diseases, such as autoimmune, allergic and inflammatory diseases, and in the prevention and/or treatment of diseases of the central nervous system (CNS), such as neurodegenerative diseases.
    Type: Grant
    Filed: January 28, 2013
    Date of Patent: August 4, 2015
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Paul Harrington, Richard W. Heidebrecht, Jr., Solomon Kattar, Thomas A. Miller, Karin M. Otte, Phieng Siliphaivanh, Matthew G. Stanton, Paul Tempest, Kevin J. Wilson, David J. Witter
  • Patent number: 8791147
    Abstract: The present invention relates generally to novel calcimimetic compounds and pharmaceutical compositions comprising them. The invention also relates to methods of treating of diseases or disorders related to the function of the calcium sensing receptor using the compounds represented in Formula (I). Where Cy1 is pyridinonyl, pyridinyl, quinolinyl or 9-ethyl-9H-beta-carbolinyl, each of which optionally substituted and where Cy2 is phenyl naphthyl.
    Type: Grant
    Filed: October 7, 2009
    Date of Patent: July 29, 2014
    Assignee: Amgen Inc.
    Inventors: Christopher Fotsch, Paul Harrington
  • Publication number: 20130137690
    Abstract: The present invention relates to a novel class of 4-carboxybenzylamino derivatives. The 4-carboxybenzylamino compounds can be used to treat cancer. The 4-carboxybenzylamino compounds can also inhibit histone deacetylase and are suitable for use in selectively inducing terminal differentiation, and arresting cell growth and/or apoptosis of neoplastic cells, thereby inhibiting proliferation of such cells. Thus, the compounds of the present invention are useful in treating a patient having a tumor characterized by proliferation of neoplastic cells. The compounds of the invention may also be useful in the prevention and treatment of TRX-mediated diseases, such as autoimmune, allergic and inflammatory diseases, and in the prevention and/or treatment of diseases of the central nervous system (CNS), such as neurodegenerative diseases.
    Type: Application
    Filed: January 28, 2013
    Publication date: May 30, 2013
    Inventors: Paul Harrington, Richard W. Heidebrecht, JR., Solomon Kattar, Thomas A. Miller, Karin M. Otte, Phieng Siliphaivanh, Matthew G. Stanton, Paul Tempest, Kevin J. Wilson, David J. Witter
  • Patent number: 8389553
    Abstract: The present invention relates to a novel class of 4-carboxybenzylamino derivatives. The 4-carboxybenzylamino compounds can be used to treat cancer. The 4-carboxybenzylamino compounds can also inhibit histone deacetylase and are suitable for use in selectively inducing terminal differentiation, and arresting cell growth and/or apoptosis of neoplastic cells, thereby inhibiting proliferation of such cells. Thus, the compounds of the present invention are useful in treating a patient having a tumor characterized by proliferation of neoplastic cells. The compounds of the invention may also be useful in the prevention and treatment of TRX-mediated diseases, such as autoimmune, allergic and inflammatory diseases, and in the prevention and/or treatment of diseases of the central nervous system (CNS), such as neurodegenerative diseases.
    Type: Grant
    Filed: June 24, 2008
    Date of Patent: March 5, 2013
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Paul Harrington, Solomon Kattar, Thomas A. Miller, Matthew G. Stanton, Paul Tempest, David J. Witter
  • Patent number: 8324396
    Abstract: The present invention relates generally to compounds represented in Formula I, pharmaceutical compositions comprising them and methods of treating of diseases or disorders related to the function of the calcium sensing receptor. The invention also relates to processes for making such compounds and to intermediates useful in these processes.
    Type: Grant
    Filed: July 10, 2008
    Date of Patent: December 4, 2012
    Assignee: Amgen Inc.
    Inventors: Pierre Deprez, Christopher Fotsch, Paul Harrington, Sarah Lively, Kanaka Pattabiraman, David St. Jean, Taoues Temal-Laib
  • Patent number: 8158825
    Abstract: The present invention relates to a novel class of modified malonate derivatives. The modified malonate compounds can be used to treat cancer. The modified malonate compounds can also inhibit histone deacetylase and are suitable for use in selectively inducing terminal differentiation, and arresting cell growth and/or apoptosis of neoplastic cells, thereby inhibiting proliferation of such cells. Thus, the compounds of the present invention are useful in treating a patient having a tumor characterized by proliferation of neoplastic cells. The compounds of the invention may also be useful in the prevention and treatment of TRX-mediated diseases, such as autoimmune, allergic and inflammatory diseases, and in the prevention and/or treatment of diseases of the central nervous system (CNS), such as neurodegenerative diseases.
    Type: Grant
    Filed: June 21, 2006
    Date of Patent: April 17, 2012
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Jonathan Grimm, Paul Harrington, Richard Heidebrecht, Jr., Thomas Miller, Karin Otte, Phieng Siliphaivanh, David Sloman, Matthew Stanton, Kevin Wilson, David Witter, Solomon Kattar, Paul Tempest
  • Publication number: 20110230517
    Abstract: The present invention relates generally to novel calcimimetic compounds and pharmaceutical compositions comprising them. The invention also relates to methods of treating of diseases or disorders related to the function of the calcium sensing receptor using the compounds represented in Formula (I). Where Cy1 is pyridinonyl, pyridinyl, quinolinyl or 9-ethyl-9H-beta-carbolinyl, each of which optionally substituted and where Cy2 is phenyl naphthyl.
    Type: Application
    Filed: October 7, 2009
    Publication date: September 22, 2011
    Inventors: Christopher Fotsch, Paul Harrington
  • Publication number: 20100324046
    Abstract: The present invention relates to a novel class of 4-carboxybenzylamino derivatives. The 4-carboxybenzylamino compounds can be used to treat cancer. The 4-carboxybenzylamino compounds can also inhibit histone deacetylase and are suitable for use in selectively inducing terminal differentiation, and arresting cell growth and/or apoptosis of neoplastic cells, thereby inhibiting proliferation of such cells. Thus, the compounds of the present invention are useful in treating a patient having a tumor characterized by proliferation of neoplastic cells. The compounds of the invention may also be useful in the prevention and treatment of TRX-mediated diseases, such as autoimmune, allergic and inflammatory diseases, and in the prevention and/or treatment of diseases of the central nervous system (CNS), such as neurodegenerative diseases.
    Type: Application
    Filed: June 24, 2008
    Publication date: December 23, 2010
    Inventors: Paul Harrington, Richard W. Heidebrecht, JR., Solomon Kattar, Thomas A. Miller, Karin M. Otte, Phieng Siliphaivanh, Paul Tempest, Kevin J. Wilson, David J. Witter
  • Patent number: D815781
    Type: Grant
    Filed: March 23, 2017
    Date of Patent: April 17, 2018
    Inventors: John Paul Harrington, Josh Stitzer
  • Patent number: D884910
    Type: Grant
    Filed: February 26, 2019
    Date of Patent: May 19, 2020
    Assignee: AVATION MEDICAL, INC.
    Inventors: Jill F. Schiaparelli, Francis Paul Harrington, Serge Roux, Benjamin Zwillinger, Anna Christina Miller, Alireza Mashal, Joyce Chien Tu
  • Patent number: D885594
    Type: Grant
    Filed: February 26, 2019
    Date of Patent: May 26, 2020
    Assignee: AVATION MEDICAL, INC.
    Inventors: Jill F. Schiaparelli, Francis Paul Harrington, Serge Roux, Benjamin Zwillinger, Anna Christina Miller, Alireza Mashal, Joyce Chien Tu